Chair Rt Hon MP has flagged significant
omissions relating to health and social care in the EU’s
negotiating mandate on the future relationship with the
UK.
The absence of health as a regulatory ‘floor’ in the
discussions is viewed as significant because it would be the
reference point for all that follows.
There are also concerns relating to the omission of
references to: substances of human origin, with potential risks
on access to these substances for the NHS; participation in the
EU’s health programme; agency-level cooperation in medicines
licensing between the Medicines and Healthcare products
Regulatory Agency and the European Medicines Agency; continued
cooperation and data sharing.
Provisions in the EU negotiating mandate are considered to have
an indirect but significant impact on health and social care with
a call to consider seeking an exemption for the NHS from certain
rules. Specifically, a non-regression clause on employment and
social protection that includes working time, and provisions on
competition rules, state aid and public procurement that could be
“particularly challenging” for the NHS and social care.
The issues are raised in a letter to Chair of the European
Scrutiny Committee Rt Hon. Sir MP in response to a call for the
view of the Health and Social Care Committee on the EU mandate
for negotiations with the UK on the future relationship.
ENDS
Note for Editors
Website
link to view full letter under
‘Correspondence from Chair to Chair of European Scrutiny
Committee’